Back to Search Start Over

The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

Authors :
Sellers WR
Loda M
Source :
Cancer cell [Cancer Cell] 2002 Nov; Vol. 2 (5), pp. 349-50.
Publication Year :
2002

Abstract

The recent finding of overexpression of the polycomb group transcriptional repressor EZH2 in prostate cancer raises the possibility that transcriptional regulation at the chromatin level may play a role in the development of the metastatic phenotype and suggests new avenues of exploration with respect to patient stratification and therapeutics.

Details

Language :
English
ISSN :
1535-6108
Volume :
2
Issue :
5
Database :
MEDLINE
Journal :
Cancer cell
Publication Type :
Academic Journal
Accession number :
12450788
Full Text :
https://doi.org/10.1016/s1535-6108(02)00187-3